These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2888737)

  • 1. Effect of bucindolol on plasma HDL cholesterol subfractions and other plasma lipids in essential hypertensive patients.
    Lehtonen A; Tanskanen A; Temmerman J
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):448-51. PubMed ID: 2888737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of nifedipine on plasma lipids in patients with essential hypertension.
    Lehtonen A; Tanskanen A; Lehto H; Jarvensiven P
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):357-8. PubMed ID: 3460970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blockade and plasma lipids.
    Lehtonen A
    J Pharmacol; 1983; 14 Suppl 2():203-8. PubMed ID: 6138468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of alpha/beta blockers on serum lipids.
    Lehtonen A
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):228-30. PubMed ID: 6114045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blocker effects on plasma lipids in antihypertensive therapy: importance of the duration of treatment and the lipid status before treatment.
    Fogari R; Zoppi A; Tettamanti F; Poletti L; Lazzari P; Pasotti C; Corradi L
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S76-80. PubMed ID: 11527140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
    Balasubramaniam S; Simons LA; Hickie JB; Chang S
    Artery; 1990; 17(2):60-70. PubMed ID: 1968740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a new alpha 1-blocker, bunazosin hydrochloride, on plasma lipid components in hypertensive patients with hypercholesterolemia.
    Yashiro A; Sugano M; Nakashima Y; Tasaki H; Kuroiwa A
    Clin Ther; 1987; 10(1):98-106. PubMed ID: 2897239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma lipids during chronic antihypertensive therapy with different beta-blockers.
    Fogari R; Zoppi A; Pasotti C; Poletti L; Tettamanti F; Malamani G; Corradi L
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S28-32. PubMed ID: 2481787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J; Kajiyama G; Kusukawa R; Mori H; Koga S; Takagi R; Tanaka N; Ogawa N; Arakawa K
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):660-4. PubMed ID: 7881705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of acebutolol on plasma apoproteins and HDL cholesterol subfractions.
    Lehtonen A; Marniemi J; Niittymäki K
    Res Commun Chem Pathol Pharmacol; 1985 Mar; 47(3):427-35. PubMed ID: 3922021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of the beta-adrenergic-blocking agents, timolol and carteolol, on plasma lipids and lipoproteins in Japanese glaucoma patients.
    Yamamoto T; Kitazawa Y; Noma A; Maeda S; Kato A; Ando Y; Ido T; Inazumi K; Hayakawa T; Goto Y; Ichien M
    J Glaucoma; 1996 Aug; 5(4):252-7. PubMed ID: 8795770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of carvedilol on serum lipids in patients with essential hypertension.
    Goto Y; Tamachi H; Fusegawa Y; Nakaya N; Homma Y; Mikami M; Iori S; Yamazaki A
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S45-50. PubMed ID: 1721979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of mepindolol on serum lipids.
    Martignoni A; Perani G; Finardi G; Mastropasqua E; Fogari R
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):543-5. PubMed ID: 7174157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in plasma HDL-cholesterol in hypertensive patients treated with enalapril.
    Perani G; Muggia C; Martignoni A; Bongarzoni A; Radaelli A; Testa F; Finardi G
    Clin Ther; 1987; 9(6):635-9. PubMed ID: 2830973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P; Eide I; Foss OP; Helgeland A; Hjermann I; Holme I; Kjeldsen SE; Lund-Larsen PG
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of celiprolol and metoprolol on serum lipids in patients with various forms of hyperlipoproteinemia].
    Pristautz H; Stradner F
    Wien Med Wochenschr; 1986 Sep; 136(17):443-8. PubMed ID: 2879389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect on HDL cholesterol of oxprenolol and atenolol.
    Kjeldsen SE; Eide I; Leren P; Foss OP; Holme I; Eriksen IL
    Scand J Clin Lab Invest; 1982 Sep; 42(5):449-53. PubMed ID: 6130595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in plasma lipids, lipoproteins and apolipoproteins in hypercholesterolaemic patients treated with pravastatin.
    Lijnen P; Celis H; Desager JP; Fagard R
    J Hum Hypertens; 1995 Jul; 9(7):557-64. PubMed ID: 7562885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.